I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed c..:
Zheng, Yulong
;
Zhu, Jianqing
;
Xiong, Jianping
...
Cancer. 130 (2024) 12 - p. 2180-2190 , 2024
Link:
https://doi.org/10.1002/cncr.35259
RT Journal T1
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death‐1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105‐204)
UL https://suche.suub.uni-bremen.de/peid=cr-10.1002_cncr.35259&Exemplar=1&LAN=DE A1 Zheng, Yulong A1 Zhu, Jianqing A1 Xiong, Jianping A1 Jiang, Ou A1 Wang, Hong A1 Xie, Yanru A1 Zhou, Yuefen A1 Xu, Nong PB Wiley YR 2024 SN 0008-543X SN 1097-0142 JF Cancer VO 130 IS 12 SP 2180 OP 2190 LK http://dx.doi.org/https://doi.org/10.1002/cncr.35259 DO https://doi.org/10.1002/cncr.35259 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)